Multifactorial causation of obesity: Implications for prevention

American Journal of Clinical Nutrition

Volumn 67, Issue 3 SUPPL., 1998, Pages

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Body mass index; Coronary heart disease; LDL cholesterol; Metabolic syndrome; Obesity; Overweight; Risk factors; Subcontinental Asians

Indexed keywords

AGING; CONFERENCE PAPER; ENERGY BALANCE; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; OBESITY; PREVALENCE; RISK FACTOR; SOCIAL CLASS; UNITED STATES;

EID: 0031908527     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.3.563S     Document Type: Conference Paper

References (114)

1. Grundy SM. Atherogenic dyslipidemia and the metabolic syndrome: pathogenesis and challenge of therapy. In: Gotto AM Jr, ed. Drugs affecting lipid metabolism. Dordrecht, Netherlands: Kluwer Academic Publishers, 1996:237-47.
2. Kannel WB. Contributions of the Framingham Study to the conquest of artery disease. Am J Cardiol 1997;1109-12.
3. National High Blood Pressure Education Program, National Cholesterol Education Program. Working group report on management of patients with hypertension and high blood cholesterol. Washington. DC: US Government Printing Office, 1990. (DHHS/NHLBI, NIH publication 90-2361.)
4. Reaven GM. Insulin resistance and its consequences: non-insulin-dependent diabetes mellitus and coronary heart disease. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes mellitus. Philadelphia: Lippincott-Reaven Publishers, 1966:509-19.
5. DeFronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
6. Howard G. O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. Circulation 1996;93:1809-17.
7. Bjorntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover rate in obesity. Acta Med Scand 1969;185:351-6.
8. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-73.
9. Campbell PJ, Carlson MG, Nurjhan N. Fat metabolism in human obesity. Am J Physiol 1994;266:E600-5.
10. Randle PJ, Priestman DA, Mistry S, Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 1994;37:S155-61.
11. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98.
12. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-93.
13. Elahi D, Nagulesparan M, Herscopf RJ. Feedback inhibition of insulin secretion by insulin: the hyperinsulinemia of obesity. N Engl J Med 1989;306:1196-202.
14. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988;319:1500-6.
15. Stein DT, Esser V, Stevenson BE, et al. Essentially of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 1996;97:1-8.
16. Zimmet P, Dowse G, Bennett PH. Hyperinsulinemia is a predictor of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1991;17:101-8.
17. Garg A, Chandalia M, Vuitch F. Severe islet amyloidosis in congenital generalized lipodystrophy. Diabetes Care 1996;19:28-31.
18. Grundy SM, Mok HY, Zech L, Steinberg D, Berman M. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 1979;63:1274-83.
19. Kesaniemi YA, Beltz WF, Grundy SM. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 1985;76:586-95.
20. Egusa G, Beltz WF, Grundy SM, Howard BV. Influence of obesity on the metabolism of apolipoprotein B in man. J Clin Invest 1985;76:596-603.
21. Miettinen TA. Cholesterol production in obesity. Circulation 1971;44:842-50.
22. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994;5:395-403.
23. Richards EG, Grundy SM, Cooper K. Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease. Am J Cardiol 1989;63:1214-20.
24. Schaefer EJ, Levy RI, Anderson DW, Dannu RN, Brewer HB. Plasma triglycerides in regulation of HDL-cholesterol. Lancet 1978;2:391-3.
25. 2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb 1992;12:814-23.
26. Depres JP, Ferland M, Joorjani S, et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 1989;9:485-92.
27. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147-53.
28. 2 in man. Atherosclerosis 1980;36:589-93.
29. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993;13:1227-35.
30. Reaven GM, Chen Y-DI. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988;4:639-52.
31. Krakower GR, Kim KH. Effect of insulin on association of acetyl CoA carboxylase phosphatase and acetyl CoA carboxylase. Biochem Biophys Res Commun 1985;130:814-20.
32. Landin K, Tengvory L, Smith U. Elevated fibrinogen and plasminogen activator (PAI-I) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990;227:273-8.
33. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plusminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991;34:457-62.
34. Juhan-Vague I, Thompson SG, Jespersen J, on behalf of the ECAT Angina Pectoris Study Group. Involvement of the hemostatic system in the insulin resistance syndrome. Arterioscler Thromb 1993;13:1865-73.
35. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
36. Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996;335: 1357-62.
37. McGill HC Jr, McMahan CA, Kruski AW, Mott GE. Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons. Arteriosclerosis 1981;1:3-12.
38. Abbott WGH, Swinburg B, Routolo G, et al. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians. J Clin Invest 1990;150:1313-9.
39. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990;264: 3018-24.
40. Strong JP, Oalmann MC, Malcom GT, Newman WP, McMahon CA. The Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Pathobiological determinants of atherosclerosis in youth (PDAY): the rationale, methodology, and selected risk factor findings. Cardiovasc Risk Factors 1992;2:22-30.
41. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Criver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease New York: McGraw Hill, 1995:1981-2030.
42. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
43. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
44. Sacks FM, Pfeffer MA, Moye L. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events Trial (CARE). Am J Cardiol 1991;68:1436-46.
45. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1992;69:377-81.
46. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995;91:2844-50.
47. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993;153:1093-103.
48. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to dyslipidemia in white American women. Arch Intern Med 1994;154:401-10.
49. Hokanson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
50. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett KC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
51. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975;1:16-9.
52. Goldbourt V, Holtzman E, Neufeld HN, Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J 1985;290:1239-43.
53. Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon 1990;36:643-96.
54. Grundy SM, Vega GL. Two different views of the relationship of hypertriglyceridemia to coronary heart disease: implications for treatment. Arch Intern Med 1992;152:28-34.
55. Hunt SC, Hopkins PN, Williams RR. Hypertension: genetics and mechanisms. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996:209-35.
56. Aronson D, Rayfield A. Diabetes and obesity. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996:327-59.
57. Nachman RL. Thrombosis and atherogenesis: molecular connections. Blood 1992;79:1897-906.
58. Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 1994;105:1-7.
59. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;273:205-11.
60. Blokstra A, Kromhout D. Trends in obesity in young adults in the Netherlands from 1974 to 1986. Int J Obes 1991;15:513-21.
61. Pagano R, LaVecchia C. Overweight and obesity in Italy, 1990-9. Int J Obes Relat Metab Disord 1994;18:665-9.
62. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes 1989;13:441-53.
63. Seidell JC. Obesity in Europe. Obes Res 1995;3(suppl 2):89S-93S.
64. Gopinath N, Chadha SL, Jain P, Shekhawat S, Tandon R. An epidemiological study of obesity in adults in the urban population of Delhi. J Assoc Physicians India 1994;42:212-5.
65. Popkin BM, Paeratakul S, Zhai F, Ge K. A review of dietary and environmental correlates of obesity with emphasis on developing countries. Obes Res 1995;3(suppl 2):145S-53S.
66. el Mugamer IT, Alizayat AS, Hossain MM, Pugh RN. Diabetes, obesity and hypertension in urban and rural people of bedouin origin in the United Arab Emirates. J Trop Med Hyg 1995;98:407-15.
67. Amine EK, Samy M. Obesity among female university students in the United Arab Emirates. J Royal Soc Health 1996;116:91-6.
68. Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight. United States, 1976-80. Vital Health Stat 11 1987; 238.
69. Federation of American Societies for Experimental Biology Life Sciences Research Office. Third report on nutrition monitoring in the United States. Washington, DC: US Government Printing Office, 1995.
70. Metropolitan Life Insurance Company. Metropolitan height and weight tables, Stat Bull Metropol Life Insur Co 1983;64:1-9.
71. National Institutes of Health. The Lipid Research Clinics population studies data book: the prevalence study. Bethesda, MD: NIH, 1979. (Publication no. 79-1527.)
72. Visser M. Deurenberg P, van Staveren WA, Hautvast JGAJ. Resting metabolic rate and diet-induced thermogenesis in young and elderly subjects: relationship with body composition, fat distribution, and physical activity level. Am J Clin Nutr 1995;61:772-8.
73. Garrow JS. Modern methods of measuring body composition. In: Whitehead RG, Prentice A. New techniques in nutritional research. San Diego: Academic Press, 1991:233-9.
74. Forbes GB. The companionship of lean and fat: some lessons from body composition studies. In: Whitehead RG, Prentice A, eds. New techniques in nutritional research. San Diego: Academic Press, 1991:317-29.
75. Garrison RJ, Kannel WB. A new approach for estimating healthy body weights. Int J Obes 1993;17:417-23.
76. Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Singh NK. Epidemiologic study of central obesity, insulin resistance and associated disturbances in the urbal population of North India. Acta Cardiol 1995;50:215-25.
77. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1991;331:397-8.
78. Hughes K, Lun KC, Yeo PPB. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Community Health 1990;44:24-8.
79. Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda. Lancet 1959;2:534-7.
80. Derry CW, Bourne DE, Sayed AR. Variations in mortality of the coloured, white and Asian population groups in the RSA, 1978-1982. Part VI. Ischaemic heart disease. S Afr Med J 1987;72:698-700.
81. Pedoe HT, Clayton D, Morris JN, Brigden W, McDonald L. Coronary heart-attacks in east London. Lancet 1975;2:833-8.
82. Balarajan R, Bulusu L, Adelstein AM, Shukla V. Patterns of mortality among migrants to England and Wales from the Indian subcontinent. Br Med J 1984;289:1185-7.
83. Beckles GLA, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NTA. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1986;1:1298-301.
84. Miller GJ, Beckles GLA, Maude GH. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St. James survey, Trinidad. Int J Epidemiol 1989;18:808-17.
85. McKeigue PM, Ferrie JE, Peirpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-61.
86. Enas EA, Garg A, Davison MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996;48:343-53.
87. Stern MP, Mitchell BD. Diabetes in Hispanic Americans. In: National Diabetes Data Group, eds. Diabetes in America. Bethesda, MD: National Institutes of Health. NIDDKD, 1995:631-59.
88. Gohdes D. Diabetes in North American Indians and Alaska natives. In: National Diabetes Data Group, eds. Diabetes in America. Bethesda, MD: National Institutes of Health, NIDDKD, 1995:683-701.
89. Tzankoff SP, Norris AH. Longitudinal changes in basal metabolism in man. J Appl Physiol 1978;45:536-9.
90. Poehlman ET, Toth MJ. Mathematical ratios lead to spurious conclusions regarding age-and sex-related differences in resting metabolic rate. Am J Clin Nutr 1995;61:482-5.
91. Poehlman ET, Berke EM, Joseph JR, Gardner AW, Katzman-Rooks SM, Goran MI. Influence of aerobic capacity, body composition, and thyroid hormones on the age-related decline in resting metabolic rate. Metabolism 1992;41:915-21.
92. Poehlman ET. Regulation of energy expenditure in aging humans. J Am Geriatr Soc 1993;41:552-9.
93. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. JAMA 1996;276:241-6.
94. US Department of Health and Human Services, Centers for Disease Control and Prevention. Physical activity and health: a report of the Surgeon General. Atlanta: National Center for Chronic Disease Prevention and Health Promotion, 1996.
95. Troiano RP, Flegal KM, Juczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends in children and adolescents: the National Health and Nutrition Examination Surveys, 1963-1991. Arch Pediatr Adolesc Med 1995;149:1085-91.
96. Flatt JP. The biochemistry of energy expenditure. In: Bray GA, ed. Obesity research II. London: Newman, 1978:221-8.
97. Flatt JP. Importance of nutrient balance in body weight regulation. Diabetes Metab Rev 1988;4:571-81.
98. Shah M, Garg A. High-fat and high-carbohydrate diets and energy balance. Diabetes Care 1996;19:1142-52.
99. Sclafani A. Dietary obesity models. In: Bjorntorp P, Brodoff BN, eds. Obesity. Philadelphia: JB Lippincott, 1992:241-8.
100. Liebel RL, Hirsch J, Appel BE, Checani GC. Energy intake required to maintain body weight is not affected by wide variation in diet composition. Am J Clin Nutr 1992;55:350-5.
101. Centers for Disease Control and Prevention. Daily dietary fat and total food energy intakes. Third National Health and Nutrition Examination Survey. Phase 1. MMWR Wkly Rep 1994;43:116-25.
102. Shah M, Hannan PJ, Jeffery RW. Secular trend in body mass index in the adult population of three communities from the upper midwestern part of the USA: the Minnesota Heart Health Program. Int J Obes 1991;15:499-503.
103. Bouchard C, Tremblay A, Despres J. The response to long-term overfeeding on identical twins. N Engl J Med 1990;322:1477-82.
104. Bluchard C, Perusse L. Genetics of obesity. Annu Rev Nutr 1993;13:337-54.
105. Misra A, Garg A. Leptin, its receptor and obesity. J Invest Med 1996;44:540-5.
106. Sinha MK, Ohannesian JP, Heiman ML, et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996;97:1344-7.
107. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996;45:699-701.
108. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996;98:201-3.
109. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-8.
110. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel II). Circulation 1994;89:1329-445.
111. Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med 1988;318:1244-8.
112. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45.
113. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410.
114. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acid: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994;59:861-8.